A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Adding Methotrexate to Etanercept in Subjects With Moderate to Severe Plaque Psoriasis.
Phase of Trial: Phase III
Latest Information Update: 09 Aug 2013
At a glance
- Drugs Etanercept (Primary) ; Methotrexate (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Amgen
- 20 Mar 2012 Results presented at the 70th Annual Meeting of the American Academy of Dermatology.
- 17 Feb 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 17 Feb 2011 Actual end date (Feb 2011) added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History